Active Ingredient History
Ulocuplumab is a monoclonal antibody designed for the treatment of hematologic malignancies. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Leukemia (Phase 1/Phase 2)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 1)
Leukemia, Myeloid, Acute (Phase 1)
Lymphoma, Follicular (Phase 1)
Lymphoma, Large-Cell, Immunoblastic (Phase 1)
Multiple Myeloma (Phase 1)
Neoplasms (Phase 2)
Waldenstrom Macroglobulinemia (Phase 1/Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue